BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23396735)

  • 1. Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease.
    Diaz-Sanchez A; Matilla A; Nuñez O; Rincon D; Lorente R; Lo Iacono O; Merino B; Hernando A; Campos R; Clemente G; Bañares R
    Ann Hepatol; 2013; 12(2):236-47. PubMed ID: 23396735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis.
    Lo Iacono O; Rincón D; Hernando A; Ripoll C; Catalina MV; Salcedo M; Clemente G; Gomez J; Nuñez O; Matilla A; Bañares R
    Liver Int; 2008 Sep; 28(8):1129-35. PubMed ID: 18482273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma.
    Ho JW; Poon RT; Tong CS; Fan ST
    World J Gastroenterol; 2004 Jul; 10(14):2014-8. PubMed ID: 15237425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma.
    Diaz-Sanchez A; Matilla A; Nuñez O; Lorente R; Fernandez A; Rincón D; Campos R; Bañares R; Clemente G
    Scand J Gastroenterol; 2013 Mar; 48(3):334-43. PubMed ID: 23249262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adhesion molecule expression and soluble fractions in hepatic resection.
    Shimada M; Kajiyama K; Hasegawa H; Gion T; Ikeda Y; Shirabe K; Takenaka K; Sugimachi K
    J Am Coll Surg; 1998 May; 186(5):534-41. PubMed ID: 9583693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage C; Gunathilaka B; Jayathunge S; de Silva HJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):401-5. PubMed ID: 26256085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.
    Spadaro A; Ajello A; Luigiano C; Morace C; Resta ML; Berlinghieri G; Campo S; Scisca C; Alibrandi A; D'Arrigo G; Alessi N; Ferrau O; Freni MA
    World J Gastroenterol; 2006 Aug; 12(29):4716-20. PubMed ID: 16937445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma.
    Iliaz R; Akyuz U; Tekin D; Serilmez M; Evirgen S; Cavus B; Soydinc H; Duranyildiz D; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
    Arab J Gastroenterol; 2016 Dec; 17(4):164-167. PubMed ID: 27916547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
    Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
    BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of serum angiotensin-converting enzyme as a tumour marker of hepatocellular carcinoma.
    Kardum D; Huskic J; Fabijanic D; Banic M; Buljevac M; Kujundzic M; Loncar B
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1209-13. PubMed ID: 10563528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentration of adhesion molecules in postoperative biliary atresia patients: relationship to disease activity and cirrhosis.
    Kobayashi H; Horikoshi K; Long L; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2001 Aug; 36(8):1297-301. PubMed ID: 11479880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
    El-Shal AS; Zidan HE; Rashad NM; Wadea FM
    Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis.
    Tomiya T; Fujiwara K
    Cancer; 1996 Mar; 77(6):1056-60. PubMed ID: 8635123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis.
    Sorvillo F; Mazziotti G; Carbone A; Morisco F; Cioffi M; Rotondi M; Stornaiuolo G; Amato G; Gaeta GB; Caporaso N; Carella C
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):207-12. PubMed ID: 12580937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
    Pompili M; Rapaccini GL; de Luca F; Caturelli E; Astone A; Siena DA; Villani MR; Grattagliano A; Cedrone A; Gasbarrini G
    Cancer; 1997 Apr; 79(8):1501-8. PubMed ID: 9118030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
    Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.